Variations of serum IgG subclass levels in hepatitis C virus infection during interferon-alpha therapy

被引：5

作者：

Musset, L

Ghillani, P

Lunel, F

Cacoub, P

Cresta, P

Frangeul, L

Rosenheim, M

Preudhomme, JL

机构：

[1] GRP HOSP PITIE SALPETRIERE,VIROL LAB,F-75651 PARIS 13,FRANCE

[2] GRP HOSP PITIE SALPETRIERE,DEPT HEPATOGASTROENTEROL,F-75651 PARIS 13,FRANCE

[3] GRP HOSP PITIE SALPETRIERE,DEPT INTERNAL MED,F-75651 PARIS 13,FRANCE

[4] GRP HOSP PITIE SALPETRIERE,PUBL HLTH UNIT,F-75651 PARIS 13,FRANCE

[5] UNIV POITIERS HOSP,LAB IMMUNOL & IMMUNOPATHOL,CNRS URA 1172,POITIERS,FRANCE

来源：

IMMUNOLOGY LETTERS | 1997年 / 55卷 / 01期

关键词：

hepatitis C virus; IgG subclass; interferon-alpha;

D O I：

10.1016/S0165-2478(96)02681-8

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Serum IgG1 levels are selectively increased in patients with chronic hepatitis C virus (HCV) infection. In 15 patients who received interferon (IFN)-alpha therapy, serum levels of immunoglobulin classes and IgG subclasses were measured during treatment and after it was discontinued. In spite of important individual variations, mean IgG, IgG1, IgA and IgM levels decreased during therapy and tended to return to pre-treatment levels afterwards, with no detectable correlation with clinical and biological parameters. These results suggest an effect of IFN-alpha on in vivo immunoglobulin production, in HCV carriers. (C) 1997 Elsevier Science B.V.

引用

页码：41 / 45

页数：5

共 50 条

[41] Detectable levels of IgM antibodies to hepatitis C virus core protein predict breakthrough in patients with chronic hepatitis C treated with interferon-alpha
Fracassetti, O
Tambini, R
Perani, V
Vicari, O
Lorenzi, N
Delvecchio, G
JOURNAL OF VIRAL HEPATITIS, 1996, 3 (05) : 265 - 266
[42] Combination therapy with interferon alpha and ribavirin for chronic hepatitis C virus infection in thalassaemic patients
Telfer, PT
Garson, JA
Whitby, K
Grant, PR
Yardumian, A
Hoffbrand, AV
Wonke, B
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 98 (04) : 850 - 855
[43] Prolonged interferon-alpha therapy of hepatitis B virus-related decompensated cirrhosis
Marcellin, P
Giuily, N
Loriot, MA
Durand, F
Samuel, D
Bettan, L
Degott, C
Bernuau, J
Benhamou, JP
Erlinger, S
JOURNAL OF VIRAL HEPATITIS, 1997, 4 : 21 - 26
[44] Plasma exchange and interferon-alpha pharmacokinetics in patients with hepatitis C virus-associated systemic vasculitis
Hausfater, P
Cacoub, P
Assogba, U
Lebon, P
Piette, JC
NEPHRON, 2002, 91 (04): : 627 - 630
[45] INTERFERON-ALPHA RETREATMENT IN CHRONIC HEPATITIS-C
GERKEN, G
TEUBER, G
GOERGEN, B
HERMANN, K
ZUMBUSCHENFELDE, KHM
JOURNAL OF HEPATOLOGY, 1995, 22 : 118 - 121
[46] Cyclosporin A inhibits hepatitis C virus replication and restores interferon-alpha expression in hepatocytes
Liu, J-P.
Ye, L.
Wang, X.
Li, J-L.
Ho, W-Z.
TRANSPLANT INFECTIOUS DISEASE, 2011, 13 (01) : 24 - 32
[47] Chronic inflammatory demyelinating polyneuropathy triggered by interferon-alpha for chronic hepatitis B virus infection
Sakaguchi, Hideya
Yamashita, Satoshi
Ueda, Akihiko
Sada, Hiromi
Ikeda, Tokunori
Hirahara, Tomoo
Honda, Shoji
Kimura, En
Yamashita, Taro
Maeda, Yasushi
Hirano, Teruyuki
Uchino, Makoto
NEUROLOGY AND CLINICAL NEUROSCIENCE, 2015, 3 (01): : 36 - 38
[48] Granulomatous hepatitis in a patient with chronic hepatitis C treated with interferon-alpha
Veerabagu, MP
Finkelstein, SD
Rabinovitz, M
DIGESTIVE DISEASES AND SCIENCES, 1997, 42 (07) : 1445 - 1448
[49] Interferon signaling in the liver during hepatitis C virus infection
Makowska, Zuzanna
Heim, Markus H.
CYTOKINE, 2012, 59 (03) : 460 - 466
[50] PREDICTION OF SUSTAINED RESPONSE TO INTERFERON-ALPHA THERAPY WITH SERUM-SOLUBLE INTERLEUKIN-2 RECEPTOR LEVELS IN PATIENTS WITH CHRONIC HEPATITIS-C
MATSUNAGA, T
KOJIMA, J
INOUE, A
ARAO, M
INTERNATIONAL HEPATOLOGY COMMUNICATIONS, 1995, 3 (04): : 173 - 177

← 1 2 3 4 5 →